Hepatobiliary disease in inflammatory bowel disease (Q34745750)

4 August 2017

1 reference

title

Hepatobiliary disease in inflammatory bowel disease. (English)

1 reference

inflammatory bowel diseases

4 August 2017

main subject

0 references

hepatobiliary disease

1 reference

Jawad Ahmad

1

1 reference

4 August 2017

Adam Slivka

series ordinal

2

1 reference

4 August 2017

publication date

1 March 2002

1 reference

Gastroenterology Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

31

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

329-345

1 reference

Primary sclerosing cholangitis: a long-term follow-up study

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: resect, dilate, or transplant?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cholelithiasis and urolithiasis in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Serum autoantibodies in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Gallstones in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Clinical course and management of inflammatory bowel disease after liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary biliary cirrhosis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Portal vein thrombosis in a complicated case of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Lithogenic bile in patients with ileal dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: liver transplantation or biliary surgery

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Pigment gallstones in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Gall Stones in Patients with Disorders of the Terminal Ileum and Disturbed Bile Salt Metabolism

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Gallstones after ileostomy and ileal resection

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Pathogenesis of gall stones in Crohn's disease: an alternative explanation

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: MR imaging features

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Microsatellite instability is absent in liver and biliary mucosa of patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A revised natural history model for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Survival and Risk of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ulcerative colitis associated with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ursodeoxycholic acid therapy in hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Bile composition in patients with ileal resection due to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cholelithiasis in inflammatory bowel disease. A case-control study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A prospective evaluation of cytology from biliary strictures.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Surgical aspects of sclerosing cholangitis. Results in 178 patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Autoimmune Hepatitis Overlapping With Primary Sclerosing Cholangitis in Five Cases

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Crohn's disease presenting as pyogenic liver abscess with review of previous case reports

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Colchicine treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Sclerosing cholangitis and biliary tract calculi--primary or secondary?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Immunohistochemical analysis of inflammation in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Four years experience with short term stenting in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Value of brush cytology for dominant strictures in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Hepatobiliary manifestations of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: MR imaging findings with pathologic correlation

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Cholangiocarcinoma complicating primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Bile acids in liver disease associated with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Chronic ulcerative colitis: incidence and prevalence in a community

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

"Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Effectiveness of combined anticoagulant therapy for extending portal vein thrombosis in Crohn's disease. Report of a case

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ulcerative colitis, primary biliary cirrhosis, and chronic pancreatitis: coincident or coexistent?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

Current concepts in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50020-6

7 January 2021

10.1016/S0889-8553(01)00020-6

Identifiers

DOI

1 reference

4 August 2017

1 reference